GLYCOMIMETICS INC (GLYC) Operating Income (Loss) USD 2012 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Glycomimetics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Glycomimetics Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$11.1 M, a 1.59% decline year-over-year.
  • Glycomimetics Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$39.4 M, a 9.69% increase year-over-year.
  • Glycomimetics Inc annual Operating Income (Loss) for 2023 was -$39.3 M, a 17.1% increase from 2022.
  • Glycomimetics Inc annual Operating Income (Loss) for 2022 was -$47.4 M, a 25.3% increase from 2021.
  • Glycomimetics Inc annual Operating Income (Loss) for 2021 was -$63.4 M, a 23.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39.3 M +$8.13 M +17.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$47.4 M +$16 M +25.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$63.4 M -$11.9 M -23.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-27
2020 -$51.5 M +$9.88 M +16.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-29
2019 -$61.4 M -$9.88 M -19.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 -$51.5 M -$17.6 M -51.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
2017 -$33.9 M -$2.02 M -6.33% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$31.9 M -$19.1 M -150% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 -$12.8 M -$1.65 M -14.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 -$11.1 M -$533 K -5.03% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$10.6 M -$14.2 M -392% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $3.64 M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.